Sterlington PLLC

Partner and Co-Head, Intellectual Property

Gregory Sephton is a Life Sciences and IP partner and Co-Head of Sterlington’s Intellectual Property practice. He has represented pharmaceutical, biotechnology and other technology innovators, including AstraZeneca, Novartis, Merck, Sanofi, and Regeneron in high-stakes patent litigation.

He has extensive experience in high-value Hatch-Waxman patent litigations against generic drug challengers. He also has litigated bet-the-company patent cases involving biologics and lipid nanoparticle technology. Leveraging his litigation experience and deep technical industry knowledge, Gregory also counsels emerging and established life sciences and cosmetics companies on protecting, licensing, and monetizing their IP assets.